Revolution Medicines (RVMD) EBIT Margin (2019 - 2023)
Revolution Medicines (RVMD) posted EBIT Margin of -24256.47% for Q4 2023, down 23853.94 percentage points from -402.52% a year earlier.
Powered by 
Analysis
Revolution Medicines (RVMD) EBIT Margin (2019 - 2023) Analysis & Trends
For FY2023, Revolution Medicines' EBIT Margin came in at -4207.12%, down 3477.11 percentage points from FY2022.
- Annual EBIT Margin has declined for four consecutive years, with a five-year change of -4007.13 percentage points (FY2018 to FY2023).
- In prior years, Revolution Medicines' EBIT Margin was -730.01% in FY2022 (-90.31 pp), -639.70% in FY2021 (-382.16 pp), -257.54% in FY2020 (-149.39 pp) and -108.15% in FY2019 (+91.84 pp).
- The Q4 2023 figure stands as the lowest quarterly EBIT Margin in data going back to Q1 2019.
- On a year-over-year basis, EBIT Margin increased in two of the last seven quarters, with an average year-over-year change of -3454.93 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q3 2022, with a gain of 2548.13 percentage points; the weakest was Q4 2023, with a drop of 23853.94 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 28.37% |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -24,256.47% |
| Jun 30, 2023 | -2,845.11% |
| Mar 31, 2023 | -1,071.53% |
| Dec 31, 2022 | -402.52% |
| Sep 30, 2022 | -2,280.48% |
| Jun 30, 2022 | -681.10% |
| Mar 31, 2022 | -764.70% |
| Dec 31, 2021 | -559.33% |
| Sep 30, 2021 | -4,828.61% |
| Jun 30, 2021 | -512.01% |
| Mar 31, 2021 | -369.13% |
| Dec 31, 2020 | -389.44% |
| Sep 30, 2020 | -217.61% |
| Jun 30, 2020 | -279.14% |
| Mar 31, 2020 | -182.59% |
| Dec 31, 2019 | -161.85% |
| Sep 30, 2019 | -108.42% |
| Jun 30, 2019 | -85.99% |
| Mar 31, 2019 | -79.26% |
API Access
Revolution Medicines EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();